SFFS
ZBH icon

Stonehage Fleming Financial Services’s Zimmer Biomet ZBH Stock Holding History

Stonehage Fleming Financial Services’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-211
Closed -$21K – 186
2020
Q1 		$21K Hold
211
– – ﹤0.01% 161
2019
Q4 		$31K Buy
+211
New +$29.1K ﹤0.01% 165

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Stonehage Fleming Financial Services's ZBH Position: Q2 2020 in Review

Stonehage Fleming Financial Services sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 211 shares — an estimated $21K sold.

Stonehage Fleming Financial Services first reported a position in ZBH in Q4 2019 and held it in 2 quarters. The position peaked at $31K in Q4 2019. 945 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • Stonehage Fleming Financial Services reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 211 Zimmer Biomet shares in Q2 2020, an estimated $21K.
  • Stonehage Fleming Financial Services first reported a position in Zimmer Biomet in Q4 2019 and held it in 2 quarters.
  • Stonehage Fleming Financial Services's Zimmer Biomet position peaked at $31K in Q4 2019.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2020, filed 13 Aug 2020.